4th GBM Drug Development Summit

At the 4th GBM Drug Development Summit, Louis-Marie Bachelot, CEO and cofounder of GlioCure, will share his views on the funding dilemma the GBM community has to face in a talk entitled:
Financing the Unfinanceable: An Optimistic Perspective From Europe
Let’s learn from history: the temozolomide precedent.
Let’s learn from others: the rare diseases examples.
Being wise, not too big, not too early: "a living dog is better than a dead lion.”